CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.015
+0.015 (0.75%)
Apr 24, 2025, 4:00 PM EDT - Market closed
CASI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CASI Pharmaceuticals stock has a target of 4.00, which predicts an increase of 98.51% from the current stock price of 2.02.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for CASI Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $4 | Strong Buy | Maintains | $6 → $4 | +98.51% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $6 | Strong Buy | Maintains | $12 → $6 | +197.77% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +495.53% | Nov 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +396.28% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +396.28% | May 22, 2023 |
Financial Forecast
Revenue This Year
47.41M
from 28.54M
Increased by 66.12%
Revenue Next Year
71.76M
from 47.41M
Increased by 51.37%
EPS This Year
-2.11
from -2.56
EPS Next Year
-1.11
from -2.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.8M | 73.9M | 93.9M | ||
| Avg | 47.4M | 71.8M | 91.3M | ||
| Low | 45.5M | 68.9M | 87.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 71.0% | 55.8% | 30.9% | ||
| Avg | 66.1% | 51.4% | 27.2% | ||
| Low | 59.6% | 45.4% | 22.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.17 | -1.14 | -1.13 |
| Avg | -2.11 | -1.11 | -1.10 |
| Low | -2.03 | -1.07 | -1.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.